Professor of Cardiology
University of Brescia
Marco Metra is Full Professor of Cardiology and Director of the Institute of Cardiology of the Civil Hospital and University of Brescia, Italy, and Editor-in-Chief of the European Journal of Heart Failure and Senior Consulting Editor of the European Heart Journal.
Prof. Metra received his medical degree in 1981 and continued post-graduate Fellowships in Internal Medicine and in Cardiology at the University of Parma, Italy. In 1985 he worked as a research associate at the Committee of Clinical Pharmacology at the University of Chicago, Illinois, under the directorship of Prof. Leon I. Goldberg, returning to work at the Cardiology Institute of Brescia in 1986.
Prof. Metra has been principal investigator and member of the Executive or Steering Committees of many trials in patients with heart failure. His research is focused on heart failure with, as main areas of interest, β-blocker therapy and, more recently, the assessment and treatment of the patients with acute heart failure. He has co-chaired with Prof. Teerlink, San Francisco, CA, the phase IIB Pre-RELAX-AHF and the phase III RELAX-AHF randomized placebo controlled trials in patients with acute heart failure and is chairing the current RELAX-AHF-2 trial, which has as primary end-points the effects of serelaxin on the 180-days mortality and on in-hospital worsening heart failure. He is also member of the Executive Committee or Data Monitoring Committees of many major trials regarding the treatment of heart failure.
Since January 2015, Marco Metra is an ex-officio member of the board of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Previously, he had also served as a HFA board member from 2001 to 2008 and as secretary of the executive board from 2004 to 2006. He has also been a member of the ESC Committee for Practice Guidelines during the years 2004 to 2008.
He is the author of more than 400 articles in peer-reviewed journals (current H index at SCOPUS, 58).